REA COLBY: Open Payments
NPI 1649835968 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,997 in 49 payments from 16 companies in 2025. Trend: 2023 $201 · 2024 $986 · 2025 $1,997
Food & beverage: $1,997
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $289 |
| Boston Scientific Corporation | 2 | $285 |
| ABIOMED | 2 | $268 |
| AstraZeneca Pharmaceuticals LP | 7 | $226 |
| Axsome Therapeutics, Inc. | 2 | $158 |
| Lilly USA, LLC | 11 | $133 |
| GlaxoSmithKline, LLC. | 2 | $117 |
| Teva Pharmaceuticals USA, Inc. | 1 | $114 |
| ABBVIE INC. | 4 | $100 |
| CVRx, Inc. | 1 | $89 |
Products named: Kerendia, Auvelity, AMS 700, WATCHMAN FLX, MOUNJARO, AUSTEDO XR, AREXVY, Barostim Neo System.
Industry payments across TX — which companies pay providers there.
